{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:47:11Z","timestamp":1792273631889,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T00:00:00Z","timestamp":1792195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12844-1","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:11:34Z","timestamp":1792231894000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Haplotype structure and functional genotype\u2013phenotype interactions of PON1 (L55M\/Q192R) variants in Egyptian children with nephrotic syndrome"],"prefix":"10.1007","volume":"53","author":[{"given":"Amal E.","family":"Gohary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally M.","family":"Shalaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henar M.","family":"Bediar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Sameh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,17]]},"reference":[{"key":"12844_CR1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.47419\/bjbabs.v2i01.38","volume":"2","author":"R Ali","year":"2021","unstructured":"Ali R, Baban R, Ali S (2021) Evaluation of lipid metabolizing enzymes: Paraxonase1 (PON1) and lecithin cholesterol acyltransferase (LCAT) activities in children with nephrotic syndrome. Baghdad J Biochem Appl Biol Sci 2:48\u201359. https:\/\/doi.org\/10.47419\/bjbabs.v2i01.38","journal-title":"Baghdad J Biochem Appl Biol Sci"},{"key":"12844_CR2","doi-asserted-by":"publisher","first-page":"621","DOI":"10.4103\/mmj.mmj_303_19","volume":"34","author":"G El-Mashad","year":"2021","unstructured":"El-Mashad G, Omar Z, Bahbah H, Esmail M (2021) Epidemiological study of nephrotic syndrome in pediatrics in Menoufia University Hospitals. Menoufia Med J 34:621. https:\/\/doi.org\/10.4103\/mmj.mmj_303_19","journal-title":"Menoufia Med J"},{"key":"12844_CR3","doi-asserted-by":"publisher","first-page":"5980","DOI":"10.3390\/molecules25245980","volume":"25","author":"A Taler-Ver\u010di\u010d","year":"2020","unstructured":"Taler-Ver\u010di\u010d A, Goli\u010dnik M, Bavec A (2020) The Structure and Function of Paraoxonase-1 and Its Comparison to Paraoxonase-2 and \u2013\u20093. Molecules 25:5980. https:\/\/doi.org\/10.3390\/molecules25245980","journal-title":"Molecules"},{"key":"12844_CR4","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s12944-021-01508-7","volume":"20","author":"C Meisinger","year":"2021","unstructured":"Meisinger C, Freuer D, Bub A, Linseisen J (2021) Association between inflammatory markers and serum paraoxonase and arylesterase activities in the general population: a cross-sectional study. Lipids Health Dis 20:81. https:\/\/doi.org\/10.1186\/s12944-021-01508-7","journal-title":"Lipids Health Dis"},{"key":"12844_CR5","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.3390\/ijms25052962","volume":"25","author":"T Sirca","year":"2024","unstructured":"Sirca T, Mure\u0219an M, Pallag A et al (2024) The Role of Polyphenols in Modulating PON1 Activity Regarding Endothelial Dysfunction and Atherosclerosis. Int J Mol Sci 25:2962. https:\/\/doi.org\/10.3390\/ijms25052962","journal-title":"Int J Mol Sci"},{"key":"12844_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.5937\/jomb0-46526","volume":"43","author":"S Mulat","year":"2024","unstructured":"Mulat S, Mihajlovi\u0107 M, Antoni\u0107 T et al (2024) Pediatric nephrotic syndrome: The interplay of oxidative stress and inflammation. J Med Biochem 43:424\u2013435. https:\/\/doi.org\/10.5937\/jomb0-46526","journal-title":"J Med Biochem"},{"key":"12844_CR7","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s10067-020-05218-w","volume":"40","author":"O Zaragoza-Garc\u00eda","year":"2021","unstructured":"Zaragoza-Garc\u00eda O, Guzm\u00e1n-Guzm\u00e1n IP, Moreno-God\u00ednez ME et al (2021) PON-1 haplotype(-108C>T, L55M, and Q192R) modulates the serum levels and activity PONase promoting an atherogenic lipid profile in rheumatoid arthritis patients. Clin Rheumatol 40:741\u2013752. https:\/\/doi.org\/10.1007\/s10067-020-05218-w","journal-title":"Clin Rheumatol"},{"key":"12844_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/5897505","volume":"2019","author":"X Pan","year":"2019","unstructured":"Pan X, Huang L, Li M et al (2019) The Association between PON1 (Q192R and L55M) Gene Polymorphisms and Risk of Cancer: A Meta-Analysis Based on 43 Studies. Biomed Res Int 2019:1\u201314. https:\/\/doi.org\/10.1155\/2019\/5897505","journal-title":"Biomed Res Int"},{"key":"12844_CR9","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1007\/978-3-540-76341-3_28","volume-title":"Pediatric Nephrology","author":"P Niaudet","year":"2009","unstructured":"Niaudet P, Boyer O (2009) Idiopathic nephrotic syndrome in children: clinical aspects. In Avner ED, Harmon WE, Niaudet P, Yoshikawa N (eds) Pediatric Nephrology, 6th edn. Springer, Berlin, Heidelberg, pp 667\u2013 702. https:\/\/doi.org\/10.1007\/978-3-540-76341-3_28"},{"key":"12844_CR10","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s11033-011-0819-x","volume":"39","author":"DM Kordi-Tamandani","year":"2012","unstructured":"Kordi-Tamandani DM, Hashemi M, Sharifi N et al (2012) Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Mol Biol Rep 39:937\u2013943. https:\/\/doi.org\/10.1007\/s11033-011-0819-x","journal-title":"Mol Biol Rep"},{"key":"12844_CR11","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.3390\/antiox12061296","volume":"12","author":"A Otocka-Kmiecik","year":"2023","unstructured":"Otocka-Kmiecik A, Or\u0142owska-Majdak M, Stawski R et al (2023) Effect of Exercise Repetitions on Arylesterase Activity of PON1 in Plasma of Average-Trained Men\u2014The Dissociation between Activity and Concentration. Antioxidants 12:1296. https:\/\/doi.org\/10.3390\/antiox12061296","journal-title":"Antioxidants"},{"issue":"11","key":"12844_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000047921","volume":"105","author":"K Lal","year":"2026","unstructured":"Lal K, Perveen A (2026) Nephrotic syndrome in children: a review. Medicine (Baltimore) 105(11):e47921","journal-title":"Medicine (Baltimore)"},{"key":"12844_CR13","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","volume":"90","author":"ND Vaziri","year":"2016","unstructured":"Vaziri ND (2016) Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences. Kidney Int 90:41\u201352. https:\/\/doi.org\/10.1016\/j.kint.2016.02.026","journal-title":"Kidney Int"},{"key":"12844_CR14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.84077","author":"M Alqudsi","year":"2025","unstructured":"Alqudsi M, Alhumaid S, Almagooshi AS et al (2025) Characteristics of dyslipidemia in primary nephrotic syndromes. Cureus. https:\/\/doi.org\/10.7759\/cureus.84077","journal-title":"Cureus"},{"issue":"03","key":"12844_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.47419\/bjbabs.v2i03.55","volume":"2","author":"R Ali","year":"2021","unstructured":"Ali R, Baban R, Ali S (2021) The association between PON1 gene polymorphisms (Q192R and L55M) and nephrotic syndrome in Iraqi children. Baghdad J Biochem Appl Biol Sci 2(03):120\u2013132","journal-title":"Baghdad J Biochem Appl Biol Sci"},{"issue":"7","key":"12844_CR16","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.4103\/jfmpc.jfmpc_403_19","volume":"8","author":"R Singh","year":"2019","unstructured":"Singh R, Bhalla K, Nanda S, Gupta A, Mehra S (2019) Correlation of spot urinary protein: creatinine ratio and quantitative proteinuria in pediatric patients with nephrotic syndrome. J family Med Prim care 8(7):2343","journal-title":"J family Med Prim care"},{"key":"12844_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2018.00428","author":"S Menon","year":"2019","unstructured":"Menon S (2019) Acute kidney injury in nephrotic syndrome. Front Pediatr. https:\/\/doi.org\/10.3389\/fped.2018.00428","journal-title":"Front Pediatr"},{"key":"12844_CR18","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1007\/978-1-4939-8628-6_11","volume-title":"Core Concepts in Acute Kidney Injury","author":"A Meyrier","year":"2018","unstructured":"Meyrier A, Niaudet P (2018) Acute Kidney Failure and Minimal Change Disease. In Waikar SS, Murray PT, Singh AK (eds) Core Concepts in Acute Kidney Injury. Springer US, New York, NY, pp 181\u2013193. https:\/\/doi.org\/10.1007\/978-1-4939-8628-6_11"},{"issue":"6","key":"12844_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1053\/j.ackd.2017.09.007","volume":"24","author":"SM Sutherland","year":"2017","unstructured":"Sutherland SM, Kwiatkowski DM (2017) Acute kidney injury in children. Adv Chronic Kidney Dis 24(6):380\u2013387","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"12844_CR20","first-page":"35","volume":"68","author":"O Fekih","year":"2017","unstructured":"Fekih O, Triki S, Rejeb J, Neffati F, Douki W, Ommezzine A, Najjar MF (2017) Paraoxonase 1 polymorphisms (L55M and Q192R) as a genetic marker of diabetic nephropathy in youth with type 1 diabetes. Endokrynologia Polska 68(1):35\u201341","journal-title":"Endokrynologia Polska"},{"issue":"2","key":"12844_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000442998","volume":"132","author":"AA Al-Eisa","year":"2016","unstructured":"Al-Eisa AA, Sukumaran VJ, Haider MZ (2016) Paraoxnase1 gene polymorphism in childhood idiopathic nephrotic syndrome. Nephron 132(2):137\u2013143","journal-title":"Nephron"},{"key":"12844_CR22","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3899\/jrheum.2023-0112","volume":"50","author":"C Charles-Schoeman","year":"2023","unstructured":"Charles-Schoeman C, Hyde C, Guan S et al (2023) Relationship Between Paraoxonase-1 Genotype and Activity, and Major Adverse Cardiovascular Events and Malignancies in Patients With Rheumatoid Arthritis Receiving Tofacitinib. J Rheumatol 50:1573\u20131580. https:\/\/doi.org\/10.3899\/jrheum.2023-0112","journal-title":"J Rheumatol"},{"issue":"11","key":"12844_CR23","volume":"13","author":"H Jakubowski","year":"2024","unstructured":"Jakubowski H (2024) The molecular bases of anti-oxidative and anti-inflammatory properties of paraoxonase 1. Antioxidants (Basel, Switzerland) 13(11):1292","journal-title":"Antioxidants (Basel, Switzerland)"},{"key":"12844_CR24","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2024.2376930","author":"EC Samouilidou","year":"2024","unstructured":"Samouilidou EC, Liaouri A, Kostopoulos V, Nikas D, Grapsa E (2024) The importance of paraoxonase 1 activity in chronic kidney disease. Ren Fail. https:\/\/doi.org\/10.1080\/0886022X.2024.2376930","journal-title":"Ren Fail"},{"key":"12844_CR25","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41467-024-44710-8","volume":"15","author":"N Ehsan","year":"2024","unstructured":"Ehsan N, Kotis BM, Castel SE et al (2024) Haplotype-aware modeling of cis-regulatory effects highlights the gaps remaining in eQTL data. Nat Commun 15:522. https:\/\/doi.org\/10.1038\/s41467-024-44710-8","journal-title":"Nat Commun"},{"key":"12844_CR26","doi-asserted-by":"crossref","unstructured":"Liu N, Zhang K, Zhao H (2008) Haplotype-Association Analysis. pp 335\u2013405","DOI":"10.1016\/S0065-2660(07)00414-2"},{"key":"12844_CR27","doi-asserted-by":"publisher","first-page":"7215","DOI":"10.1038\/s41598-023-34396-1","volume":"13","author":"JF Menezes","year":"2023","unstructured":"Menezes JF, Carvalho MOS, Rocha LC et al (2023) Role of paraoxonase 1 activity and PON1 gene polymorphisms in sickle cell disease. Sci Rep 13:7215. https:\/\/doi.org\/10.1038\/s41598-023-34396-1","journal-title":"Sci Rep"},{"key":"12844_CR28","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.3390\/jcm12031199","volume":"12","author":"J Watanabe","year":"2023","unstructured":"Watanabe J, Kotani K, Gugliucci A (2023) Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis. J Clin Med 12:1199. https:\/\/doi.org\/10.3390\/jcm12031199","journal-title":"J Clin Med"},{"key":"12844_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1065967","author":"PN Durrington","year":"2023","unstructured":"Durrington PN, Bashir B, Soran H (2023) Paraoxonase 1 and atherosclerosis. Front Cardiovasc Med. https:\/\/doi.org\/10.3389\/fcvm.2023.1065967. 10:","journal-title":"Front Cardiovasc Med"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12844-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12844-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:01:42Z","timestamp":1792270902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12844-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,17]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12844"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12844-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,17]]},"assertion":[{"value":"1 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was obtained from the Ethics Committee of the Faculty of Medicine, Zagazig University (Institutional Review Board No. ZU-IRB-187\/3-March-2024). Written informed consent was obtained from the parents or legal guardians of all participants before enrollment. All study procedures were conducted in accordance with the ethical standards of the World Medical Association Declaration of Helsinki for research involving human participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. No individual-level identifying information or images are included in this manuscript that require consent for publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. This was an observational case\u2013control study, not a clinical trial.","order":4,"name":"Ethics","label":"Clinical Trial Registration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1757"}}